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1 Introduction
Magnesium is a major cation in the human body involved 
in many chemical and physiological functions, including 
synthesis of fatty acids and proteins, metabolism of diet, 
and transmission of nerve impulses. It is a cofactor for more 
than 300 metabolic reactions in the body. These process-
es include protein synthesis, cellular energy production 
and storage, cell growth and reproduction, DNA and RNA 
synthesis, and stabilization of mitochondrial membranes. 
Therefore, magnesium plays an important role in disease 
prevention and human health.1–7
Low levels of magnesium, i.e. hypomagnesemia, have 
been associated with a number of chronic diseases in-
cluding migraine headaches, Alzheimer’s disease, stroke, 
cardiovascular disease, and Type 2 diabetes. People with 
magnesium deficiency must increase their intake of mag-
nesium, usually in the form of various pharmaceutical sup-
plements.8–13 Magnesium oxide is a common form of mag-
nesium supplement that is widely available in pharmacies 
because it is less expensive than other forms (i.e. citrate, 
chloride, and amino acid gluconate). Moreover, magnesi-
um oxide contains about 60 % elemental magnesium. An-
other reason could be the differences in the bioavailabil-
ity between different magnesium salts. Good solubility of 
magnesium salts in water is important for its bioavailability. 
The studies demonstrate that organic Mg salts have a high-
er solubility than inorganic salts.14,15 
Several reagents in colorimetric as well as spectrophoto-
metric methods for the determination of magnesium have 
been described in the literature, such as eriochrome black 
T (EBT), titan yellow (TY), ammonium phosphate method, 
ethylenediaminetetraacetic acid (EDTA), paratolyl-2-the-
nohydroxamic acid and quinalizarin, 4-methyl-3-((1-H-
Indol-3-iyl)(phenyl)methyl)-1-H-Indol (MPBIM), and triz-
ma-chloranilate.16–21 All of these procedures require a true 
solution of a coloured magnesium complex in which the 
colour intensity is directly proportional to the magnesium 
concentration. 
The aim of this work was to determine the total content of 
magnesium oxide in supplements from different manufac-
turers available in pharmacies in Sarajevo using modified 
spectrophotometric method. Modification was aimed at 
shortening the time of colour development by addition of 
solid EBT instead of its solution. Thus, the problems asso-
ciated with EBT in the form of an unstable solution were 
prevented. This modification changes none of the parame-
ters of standard eriochrome black T method.
2 Experimental 
The magnesium supplements (a common form of magne-
sium as magnesium oxide, MgO) of various manufactur-
ers were bought from pharmacies in Sarajevo, as follows: 
Maxi Mag-magnezijum 375 mg+Vitamin B6 (NATUR 
PRODUCT PHARM), Magnezium-Lek® Direkt (SANDOZ), 
MagnEasyum Forte (MINERALI ZDRAVLJA) with declared 
contents of magnesium in tablets as 375 mg, 300 mg, and 
400 mg, respectively. For analysis, the supplements were 
marked as Sample I, Sample II, and Sample III.
Total content of magnesium oxide (MgO) of each supple-
ment was determined by spectrophotometry, in triplicate, 
using minor modified eriochrome black T (EBT) method.17 
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Received December 11, 2018
Accepted March 18, 2019
Š. Mandal,* A. Alispahić, A. Dedić, and H. Džudžević-Čančar This work is licensed under a Creative Commons Attribution 4.0 
International License
University of Sarajevo, Faculty of Pharmacy, Department of Natural Sciences in Pharmacy  
Zmaja od Bosne 8 (Campus), 71 000 Sarajevo, Bosnia and Herzegovina
Abstract
Magnesium is an essential element and the intracellular divalent cation involved in many biochemical functions. People with 
magnesium deficiency must increase their intake of magnesium, usually in the form of various supplements. A common form 
of magnesium supplement widely available in pharmacies is magnesium oxide (MgO). In this work, the content of MgO was 
determined in pharmaceutical supplementations using spectrophotometry, based on the reaction between magnesium ions 
and eriochrome black T at a wavelength of 535 nm. The analysed content of MgO ranged from 360.5 to 386.5 mg MgO, which 
corresponds to the daily Mg recommended values (300 to 400 mg).
Keywords
Magnesium, magnesium oxide, supplementation
* Corresponding author: Šaćira Mandal, Associate Professor, PhD
  Email: sacira.mandal@ffsa.unsa.ba
198   Š. MANDAL et al.: Spectrophotometric Determination of Magnesium Oxide Content in..., Kem. Ind. 68 (5-6) (2019) 197−200
2.1 Sample preparation
Samples of tested MgO supplements (0.30 g each) were 
dissolved in 1.0 ml of 6 M hydrochloric acid, and dilut-
ed with distilled water to mark (50 ml). Working solutions 
of all samples (5.0 ml) were prepared in triplicate, and 
measured with a “Spectronic Genesys 2” spectrophotom-
eter (Thermo Electron Corporation, Madison, USA) after 
complexation of Mg2+ ions with EBT (Sodium 1-[1-Hydrox-
ynaphthylazo]-6-nitro-2-naphthol-4-sulfonate) in an am-
monia buffer.
2.2 Reagent and standard solutions preparation
All reagents were of analytical grade (p.a.), while distilled 
water (Milli-Q, Millipore) was used for samples dilution 
and labware washing. Solutions of eriochrome black T 
method, EBT (Merck, Germany) are unstable even when 
freshly prepared and thus useless for complexation and 
formation of analyte dye (with Mg2+ ions). Therefore, EBT 
was added directly to the analysed and standard solu-
tions, precisely weighed to 0.1 g of salt during analysis and 
construction of calibration curve. Standard stock solution 
(γ(Mg2+) = 1 mg ml−1) of magnesium (II) ions was prepared 
by dissolving 0.4180 g of magnesium (II) chloride (Sig-
ma-Aldrich Co. LLC) in a few mL of 6 M hydrochloric acid 
(Merck, Darmstadt, Germany), and diluted with deionized 
water in a volumetric flask (50 ml). 
The calibration solutions were prepared by pipetting al-
iquots of 0.05, 0.10, 0.25, 0.50, 0.75, 1.00, 1.50, 2.00, 
and 2.50 ml, respectively, of the stock standard solution 
into volumetric flasks (10 ml), then, to each volumetric 
flask, adding 1.00 mL of ammonia buffer, 0.1 g of EBT and 
distilled water to obtain a concentration range of Mg from 
0.0383 to 0.2049 mmol ml−1. Ammonia buffer solution 
was prepared by dissolving 54.0 g of ammonia chloride in 
200 mL of water, and adding 350 mL of 10 M ammonia, 
then diluting it with water to 1000 ml.
The absorbance of each working solution was measured 




c(Mg2+) ⁄ mol l−1
Fig. 1 – Calibration curve
Slika 1 – Kalibracijska krivulja
2.3 Total MgO content determination
For determination of magnesium oxide content in select-
ed commercially available pharmaceutical supplements 
of magnesium, working solutions of all nine samples were 
treated with EBT and ammonia buffer as mentioned above 
for standard stock solutions of Mg2+ ions. Reaction between 
magnesium ions and eriochrome black T is favourable in 
basic medium (pH = 10) and room temperature; there-
fore, an ammonia buffer was added, and measurement 
was performed on a wavelength of 535 nm. Working wave-
length was chosen by analysing the spectrogram obtained 
by measuring absorbance A in function of wavelength, λ 
as the maximum wavelength gives the best sensitivity and 
accuracy. The optimal wavelength (λmax) for measuring ab-
sorbance is the wavelength that is most absorbed by the 
analyte in question. Practically, measurements made by 
scanning the absorbance of standard solution colour inten-
sity enabled us to observe the maximum peak at which the 
highest absorbance was recorded.
In neutral or somewhat basic solutions (i.e., pH = 10), 
eriochrome black T is a double dissociated ion, HIn2−, 
which is blue in colour. When this free form of EBT reacts 
with magnesium ions, a pink coloured complex is formed 
(Fig. 2). 
Fig. 2 – Reaction between magnesium ions and eriochrome black T
Slika 2 – Reakcija između magnezijevih iona i eriokrom crnog T
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3 Results and discussion
Spectrophotometric analysis was carried out with EBT as 
an easily available and low cost indicator. In addition, we 
simplified the colouration of analysed samples and stability 
of Mg-EBT complex by adding solid salt and avoiding long-
term addition of freshly prepared EBT solution to each in-
dividual solution of working and analysed samples.
The daily intake requirement in adults is about 400 mg, 
but when used as a treatment, magnesium is often recom-
mended at doses of 250 to 600 mg for adults. Comparison 
of the recommended intake doses with the MgO content 
declared and measured in selected commercially available 
samples, showed good agreement. The analysed content 
of MgO in the three supplements of various manufacturers 
available in pharmacies in Sarajevo ranged from 290.4 to 
398.5 mg MgO. Results are presented in Table 1 as mean 
± SD for Sample I, Sample II, and Sample III, respectively.
Table 1 – Total content of MgO in analysed supplements 
Tablica 1 – Ukupni sadržaj MgO u analiziranim pripravcima
Components
Komponente




Sample I, mg MgO 374.7 ± 5.5 375
Sample II, mg MgO 290.4 ± 1.3 300
Sample III, mg MgO 398.5 ± 5.3 400
* Data presented as mean ±SD
As may be seen from Table 1, the difference between de-
clared and true MgO content was lowest in Sample III. 
Although the other two measured samples showed no sig-
nificant deviations, all three analysed samples in a single 
capsule dose contain approximately the recommended 
daily dose of magnesium in the form of magnesium oxide.
Nowadays, magnesium in the form of magnesium oxide 
is used as a dietary supplement for various disorders and 
medical conditions, such as neurological (migraine, insom-
nia, Alzheimer disease, etc.), vascular disease (hyperten-
sion, stroke, CVD, CAD), diabetes and prediabetes, during 
pregnancy, etc.1,4,22–26
4 Conclusion
Commercially available Mg-supplements in pharmacies in 
Sarajevo were tested with the purpose of determining the 
MgO content. Based on the obtained results, the conclu-
sions can be drawn as follows: the analysed supplements 
of MgO commonly used, can be considered as a good 
source of magnesium in pharmaceutical products, as they 
showed that the declared value of MgO corresponds with 
recommended daily doses. In addition, sample prepara-
tion, complexation of magnesium ions with solid EBT, and 
spectrophotometric measurement are simple, not time 
consuming and applicable for determination of MgO in 
commercial supplements. 
List of abbreviations and symbols 
Popis kratica i simbola
EBT – eriochrome black T
– eriokrom crnog T
TY – titan yellow
– indikator titan žuto
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SAŽETAK
Spektrofotometrijsko određivanje sadržaja magnezijeva oksida u 
pripravcima s magnezijem
Šaćira Mandal,* Amra Alispahić, Alema Dedić i Hurija Džudžević-Čančar
Magnezij je esencijalni element i intrastanični dvovalentni kation uključen u više biokemijskih 
funkcija. Osobe s manjkom magnezija moraju ga dodatno unositi i to često u obliku različitih 
pripravaka. Magnezijev oksid (MgO) najčešći je oblik pripravka s magnezijem koji je široko dostu-
pan u ljekarnama. U ovom radu spektrofotometrijom je određen sadržaj MgO u farmaceutskim 
dodatcima temeljen na reakciji između magnezijevih iona i eriokrom crnog T na valnoj duljini od 
535 nm. Analizirani sadržaj MgO kretao se u rasponu od 360,5 do 386,5 mg MgO, što odgovara 
dnevnim preporučenim vrijednostima unosa Mg (300 do 400 mg).
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